Table 1. Basic patient characteristics.
| Characteristics | aTS (n=33) | SOX (n=37) | P value |
|---|---|---|---|
| Age (years) | 0.280 | ||
| Median [range] | 65.45 [46–78] | 62.97 [36–75] | |
| Sex, n (%) | 0.820 | ||
| Male | 24 (72.7) | 26 (70.3) | |
| Female | 9 (27.3) | 11 (29.7) | |
| Disease site, n (%) | 0.469 | ||
| Cardia | 18 (54.5) | 19 (51.4) | |
| Gastric fundus | 1 (3.0) | 0 (0.0) | |
| Gastric body | 5 (15.2) | 10 (27.0) | |
| Gastric antrum | 9 (27.3) | 8 (21.6) | |
| Histology, n (%) | 0.906 | ||
| Well differentiated | 0 (0.0) | 0 (0.0) | |
| Moderately differentiated | 2 (6.1) | 2 (5.4) | |
| Poorly differentiated | 31 (93.9) | 35 (94.6) | |
| Site of metastases, n (%) | |||
| Liver | 12 (36.4) | 19 (51.4) | 0.208 |
| Lung | 2 (6.1) | 3 (8.1) | 0.740 |
| Retroperitoneal lymph nodes | 19 (57.6) | 15 (40.5) | 0.155 |
| Others | 13 (39.4) | 20 (54.1) | 0.220 |
| Cycles of first-line chemotherapy | 0.186 | ||
| Mean ± standard deviation | 4.81±1.42 | 4. 49±1.75 | |
| Cycles of posterior line chemotherapy | 0.544 | ||
| Mean ± standard deviation | 2.1±2.19 | 2.04±3.15 | |
aTS, albumin-bound paclitaxel combined with S-1; SOX, standard S-1 and oxaliplatin.